Atlas Trials

Phase I/II Study of AloCelyvir in Patients With Metastatic Uveal Melanoma

Clinical trial NCT05047276 · UNKNOWN

Trial details

NCT number
NCT05047276
Sponsor
José María Piulats Rodríguez
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Uveal Melanoma, Metastatic
Start date
2021-10-01
Primary completion
2023-06-30
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.